scispace - formally typeset
G

Guanghui Ma

Researcher at Chinese Academy of Sciences

Publications -  519
Citations -  21012

Guanghui Ma is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Membrane emulsification & Antigen. The author has an hindex of 66, co-authored 497 publications receiving 17108 citations. Previous affiliations of Guanghui Ma include Center for Advanced Materials & Nanjing Tech University.

Papers
More filters
Journal ArticleDOI

Single-Chromophore-Based Therapeutic Agent Enables Green-Light-Triggered Chemotherapy and Simultaneous Photodynamic Therapy to Cancer Cells

TL;DR: The preliminary biological experiment results have verified the efficient photorelease of chlorambucil from B-Cbl-3 and the huge contrast in cytotoxicity between them, superior combined therapeutic performance based on extraordinary low doses of drug and light irradiation, and ratiometric fluorescence imaging for in situ monitoring drug release.
Journal ArticleDOI

Double emulsion-templated microspheres with flow-through pores at micrometer scale

TL;DR: In this paper, two different polymers, poly(vinylbenzyl chloride) and poly(methyl methecrylate-2-hydroxyethyl methacrylate), were respectively employed as the major component of the particle material and amphiphilic polymer methoxy poly (ethylene glycol)-b-poly (D, L-lactide) was employed as an essential additive.
Journal ArticleDOI

Microenvironment-Responsive Three-Pronged Approach Breaking Traditional Chemotherapy to Target Cancer Stem Cells for Synergistic Inoperable Large Tumor Therapy

TL;DR: Three-pronged nanoparticles that can efficiently prohibit the proliferation of large tumor are developed for inoperable large tumor therapy and induce the apoptosis of differentiated cancer cells, cancer stem cells, and vascular niches simultaneously.
Journal ArticleDOI

Synthetic Particles for Cancer Vaccines: Connecting the Inherent Supply Chain.

TL;DR: The potential of the particulate cancer vaccines to recapitalize the inherent host immune responses for the maximum antitumor effect is illustrated and optimized synthetic particles may shed light on the development of safe and effective particulate cancers.
Journal ArticleDOI

The potential adjuvanticity of quaternized chitosan hydrogel based microparticles for porcine reproductive and respiratory syndrome virus inactivated vaccine.

TL;DR: Gel MPs, ionic cross-linked with glycerophosphate (GP), were biocompatible and could efficiently adsorb the inactivated PRRSV vaccine with a loading capacity of 579.05μg/mg and results suggested that Gel MPs elicited significantly higher cell-mediated immune responses and comparable humoral immune responses compared to ISA 206.